Great Elm Group, Inc.
NASDAQ:GEG · NASDAQ Global Select
-$0.09 today
Vol 0.09M · Avg 0.01M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
18.3%
avg -20.6%
ROIC
-5.5%
avg -9.3%
ROA
8.4%
avg -5.4%
Analysis
ROE is currently the strongest return metric at 18.3% versus its period average of -20.6%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jason W. Reese | Chief Executive Officer & Executive Chairman | $1.00M | — | 61 | $1.00M | 3.20% |
Adam Michael Kleinman | President & Secretary | $676,300.00 | — | 51 | $585,394.00 | 1.87% |
Nichole Milz | Chief Operating Officer | $638,800.00 | — | 51 | $194,884.00 | 0.62% |
Keri A. Davis | Chief Financial Officer & Chief Accounting Officer | $349,100.00 | — | 42 | $43,436.00 | 0.14% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -33.1% | +14.9% (12yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at -33.1% over three years. Forward estimates point to Revenue at +14.9% (12yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Edap Tms S.a.
EDAP
$178.23M
Assertio Holdings, Inc.
NASDAQ:ASRT
$151.86M
Immunic, Inc.
NASDAQ:IMUX
$139.40M
Adicet Bio, Inc.
NASDAQ:ACET
$75.91M
XBiotech Inc.
NASDAQ:XBIT
$71.65M
Forian Inc.
FORA
$67.79M
TScan Therapeutics, Inc.
NASDAQ:TCRX
$55.88M
Pulmonx Corporation
NASDAQ:LUNG
$54.37M
Nutriband Inc.
NTRB
$38.41M
Lite Strategy, Inc.
LITS
$29.34M
Who manages GEG?
Great Elm Group, Inc. (GEG) lists 4 active executives. The top listed executive is Jason W. Reese, Chief Executive Officer & Executive Chairman.
Are GEG insiders buying or selling?
Recent insider activity shows net buying of $8.32M.
Explore More
Continue the stock analysis
Jump to another research area for this company.